UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1259-1266

2016

Link zum Volltext

Verfügbarkeit prüfen

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1279-1286

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Inflammatory bowel diseases, 2017-11, Vol.23 (11), p.2011-2017

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

Inflammatory bowel diseases, 2011-06, Vol.17 (6), p.1301-1307

2011

Link zum Volltext

Verfügbarkeit prüfen

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]

Journal of Crohn's and colitis, 2019-09, Vol.13 (9), p.1097-1104

2019

Link zum Volltext

Verfügbarkeit prüfen

What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention

Clinical and experimental dermatology, 2019-06, Vol.44 (4), p.363-369

2019

Link zum Volltext

Verfügbarkeit prüfen

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Inflammatory bowel diseases, 2017-06, Vol.23 (6), p.946-955

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD

Journal of Crohn's and colitis, 2010-10, Vol.4 (4), p.444-449

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience

Journal of Crohn's and colitis, 2015-03, Vol.9 (3), p.252-258

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimizing thiopurine therapy in inflammatory bowel disease

Inflammatory bowel diseases, 2011-06, Vol.17 (6), p.1428-1435

2011

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1257-1258

2016

Link zum Volltext

Verfügbarkeit prüfen

Thiopurine treatment in inflammatory bowel disease: Response predictors, safety, and withdrawal in follow-up

Journal of Crohn's and colitis, 2012-06, Vol.6 (5), p.588-596

2012

Link zum Volltext

Verfügbarkeit prüfen

Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment

Journal of Crohn's and colitis, 2014-06, Vol.8 (6), p.558-559

2014

Link zum Volltext

Verfügbarkeit prüfen

Azathioprine or 6‐mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications

Inflammatory bowel diseases, 2002-09, Vol.8 (5), p.311-316

2002

Link zum Volltext

Verfügbarkeit prüfen

Use of methotrexate in refractory Crohn's disease: The Edinburgh experience

Inflammatory bowel diseases, 2008-06, Vol.14 (6), p.756-762

2008

Link zum Volltext

Verfügbarkeit prüfen

Spot diagnosis: Eruptive melanocytic naevi during azathioprine therapy in Crohn's disease

Journal of Crohn's and colitis, 2012-06, Vol.6 (5), p.636-636

2012

Link zum Volltext

Verfügbarkeit prüfen

Indicators of clinical response to treatment with six‐mercaptopurine or azathioprine in patients with inflammatory bowel disease

Inflammatory bowel diseases, 2004-07, Vol.10 (4), p.339-345

2004

Link zum Volltext

Verfügbarkeit prüfen

Increased stimulation threshold in a patient with autoimmune disease: successful management with oral prednisolone and azathioprine

Europace (London, England), 2009-04, Vol.11 (4), p.527-529

2009

Link zum Volltext

Verfügbarkeit prüfen

Use of 6‐mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease. Pro

Inflammatory bowel diseases, 2005-02, Vol.11 (2), p.197-199

Hyams, Jeffrey S.

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of 6‐mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease. Con

Inflammatory bowel diseases, 2005-02, Vol.11 (2), p.200-202

Griffiths, Anne M.

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of 6‐mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease. Balance

Inflammatory bowel diseases, 2005-02, Vol.11 (2), p.203-205

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppressors for inflammatory bowel disease: how long is long enough?

Inflammatory bowel diseases, 2000-08, Vol.6 (3), p.251-257

Modigliani, R

2000

Link zum Volltext

Verfügbarkeit prüfen

Withdrawal of steroids from triple‐drug therapy in kidney transplant patients

Nephrology, dialysis, transplantation, 2000-07, Vol.15 (7), p.1041-1045

2000

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs

Clinical and experimental immunology, 2002-02, Vol.127 (2), p.293-302

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil

Nephrology, dialysis, transplantation, 1999-02, Vol.14 (2), p.394-399

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

ThemaImmunosuppressive Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Azathioprine - Therapeutic Use
(44)
Gastroenterology & Hepatology
(36)
Female
(34)
Male
(33)
Adult
(30)
Immunosuppressive Agents - Administration & Dosage
(27)
Azathioprine - Administration & Dosage
(26)
Middle Aged
(25)
Drug Therapy, Combination
(21)
Crohn Disease - Drug Therapy
(20)
Retrospective Studies
(18)
Adolescent
(17)
Azathioprine
(17)
Treatment Outcome
(17)
Young Adult
(16)
Aged
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]

What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD

Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience

Optimizing thiopurine therapy in inflammatory bowel disease

Adalimumab and Azathioprine Combination Therapy for Crohn’s Disease: A Shining Diamond?

Thiopurine treatment in inflammatory bowel disease: Response predictors, safety, and withdrawal in follow-up

Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment

Azathioprine or 6‐mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications

Use of methotrexate in refractory Crohn's disease: The Edinburgh experience

Spot diagnosis: Eruptive melanocytic naevi during azathioprine therapy in Crohn's disease

Indicators of clinical response to treatment with six‐mercaptopurine or azathioprine in patients with inflammatory bowel disease

Increased stimulation threshold in a patient with autoimmune disease: successful management with oral prednisolone and azathioprine

Use of 6‐mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease. Pro

Use of 6‐mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease. Con

Use of 6‐mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease. Balance

Immunosuppressors for inflammatory bowel disease: how long is long enough?

Withdrawal of steroids from triple‐drug therapy in kidney transplant patients

Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs

Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil

Aktive Filter

Suchergebnisse filtern